Skip to main content

Table 1 Demographics and cardiovascular magnetic resonance (CMR) data among COVID-19 + soldiers (soldier cases) compared to healthy soldier controls

From: Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case–control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC)

 

Soldier cases

(N = 50)

Soldier healthy controls

(N = 50)

P value

Age, median (IQR), years

26.5 (23, 31)

25 (23, 33)

0.82

Height, cm

178 (175, 183)a

177 (173, 185)

0.95

Weight, kg

87 (78, 99)a

86 (75, 98)

0.83

Body surface area, kg/m2

2.1 (2.0, 2.2)b

2.1 (1.9, 2.2)

0.80

Gender, male

49 (98%)

49 (98%)

0.75

Active duty

49 (98%)

49 (98%)

1.00

Creatinine, mg/dL

0.9 (0.9, 1.0)c

1.1 (1.0, 1.2)c

n/a

Hematocrit, %

44 (43, 46)a

42 (41, 44)d

n/a

Acute cardiovascular symptoms, N, %

42 (86%)

n/a

n/a

(*Convalescent) CV symptoms

46 (94%)

n/a

 

 Dyspnea on exertion

41 (84%)

3 (6%)

 < 0.001

 Chest pain

35 (71%)

21 (42%)

0.005

 Palpitations

9 (18%)

6 (12%)

0.401

COVID-19 severity N (%)

   

 Mild (no CV symptoms)

2 (4%)

n/a

n/a

 Moderate (CV symptoms)

42 (86%)

n/a

 Severe (hospitalized)

3 (6%)

 Severe (ICU)

2 (4%)

CV PASC

   

 Survey completion, N, %

19 (39%)

n/a

n/a

 Median time to survey (days)

91

 Ongoing CV symptoms

6 (32%)

Laboratory

 Troponin I > 99%

2 (4%)a

0 (0%)e

n/a

 Abnormal ECG

4 (8.5%)a

9 (28%)f

0.05

 Hematocrit

44 (43, 45)c

42 (41, 43)d

0.06

  1. CV cardiovascular, ECG electrocardiogram, ICU intensive care unit, n/a not applicable
  2. *Convalescent CV symptoms for soldier cases, compared to any CV symptoms for controls
  3. aN = 48
  4. bN = 47
  5. cN = 14
  6. dN = 7
  7. eN = 9
  8. fN = 32